Importance of a new tumor market TRA-1-60 in the follow-up of patients with clinical stage I nonseminomatous testicular germ cell tumors

Background: TRA-1-60 is a new tumor marker for embryonal carcinoma-positive nonseminomatous testicular germ cell tumors (NSTGCT). Upper normal reference value (RV) and serum half-life (t1/2) were determined. The value was determined in the follow-up of 154 patients with stage I NSTGCT.Methods: TRA-1...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Annals of surgical oncology 1997-06, Vol.4 (4), p.321-327
Hauptverfasser:	Gels, Mariël E., Marrink, Jan, Visser, Petra, Sleijfer, Dirk Th, Droste, Jos H. J., Hoekstra, Harald J., Andrews, Peter W., Schraffordt Koops, Heimen
Format:	Artikel
Sprache:	eng
Schlagworte:	Chorionic gonadotropin Computed tomography Gonadotropins Orchidectomy Pituitary (anterior) Testes Tumor markers Tumors α-Fetoprotein
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!